Market revenue in 2020 | USD 119.3 million |
Market revenue in 2028 | USD 223.8 million |
Growth rate | 8.2% (CAGR from 2020 to 2028) |
Largest segment | Laboratory technologies |
Fastest growing segment | Online Technologies |
Historical data | 2020 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Laboratory Technologies, Online Technologies |
Key market players worldwide | Thermo Fisher Scientific Inc, Pfizer Inc, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Merck KGaA, Qiagen NV, Shimadzu Corp, Eurofins Scientific SE, Charles River Laboratories International Inc, Takara Bio Inc, Olympus Corp, Avantor Inc, Aurora Innovation Inc Class A, Standard BioTools Inc, Celerion, Cole-Parmer, Hartford Schroders International Stk I, Revvity Inc, Fluidigm Corporation, Polyplus-transfection, Hamilton Lane Inc Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 vaccine development tools market will help companies and investors design strategic landscapes.
Laboratory technologies was the largest segment with a revenue share of 95.98% in 2020. Horizon Databook has segmented the South Africa covid-19 vaccine development tools market based on laboratory technologies, online technologies covering the revenue growth of each sub-segment from 2020 to 2028.
South Africa is anticipated to witness lucrative growth rate during the forecasted period, owing to increasing number of initiatives by players to establish a manufacturing facility in the region. As of February 2022, only 11.7% of the population in South Africa is fully vaccinated, as the supply of vaccines and lack of cold chain infrastructure contributed to the low rate of vaccination in the region.
Various biotech companies and WHO decided to transfer technology to produce and distribute COVID-19 vaccines in South Africa. For instance, in February 2022, Biotech collaborated with Pfizer to set up a modular plant for producing mRNA vaccine in Africa and selling it at a breaking-even price.
Similarly, Techno Vax, Merck, and Innovative Biotech established a partnership to enable local vaccine manufacturing process in Africa. Innovative Biotech and Techno Vax use a particular method to develop the vaccine known as virus-like particle technology.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa covid-19 vaccine development tools market , including forecasts for subscribers. This country databook contains high-level insights into South Africa covid-19 vaccine development tools market from 2020 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account